3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
105
Myelodysplastic Syndromes
101
Lymphoma, Non-Hodgkin
94
Leukemia, Lymphocytic, Chronic, B-Cell
94
Hodgkin Disease
88
Multiple Myeloma
82
Leukemia
73
Lymphoma, Mantle-Cell
63
Lymphoma, Follicular
62
Lymphoma
62
Lymphoma, Large B-Cell, Diffuse
59
Myeloproliferative Disorders
55
Lymphoma, B-Cell, Marginal Zone
55
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
54
Burkitt Lymphoma
50
Leukemia, Myelomonocytic, Chronic
48
Congenital Abnormalities
46
Leukemia, Myeloid, Chronic-Phase
45
Lymphoma, Large-Cell, Immunoblastic
42
Leukemia, Myeloid, Accelerated Phase
39
Anemia, Refractory, with Excess of Blasts
36
Hematologic Neoplasms
35
Waldenstrom Macroglobulinemia
34
Primary Myelofibrosis
34
Graft vs Host Disease
34
Blast Crisis
31
Neoplasms, Plasma Cell
30
Recurrence
28
Dendritic Cell Sarcoma, Interdigitating
28
Interventions
telitacicept
2
Prednisone
2
Blood Specimen Collection
2
thymoglobulin
1
remdesivir
1
prednylidene
1
fludarabine
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
apremilast
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Music Therapy
1
Methods
1
Melphalan
1
Mastectomy, Segmental
1
Mammaplasty
1
Interviews as Topic
1
Infliximab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Autoimmune Diseases
×
Mycophenolic Acid
×
Clear all
NCT03490539
2021-02-03
PROMISE-MG
Duke University
Completed
167 enrolled